Harvard Bioscience (HBIO) Expected to Announce Earnings on Wednesday

Harvard Bioscience (NASDAQ:HBIO) is projected to release its earnings data before the market opens on Wednesday, March 12th. Analysts expect Harvard Bioscience to post earnings of $0.07 per share and revenue of $24.15 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Harvard Bioscience Trading Down 5.5 %

NASDAQ HBIO opened at $0.77 on Tuesday. The stock’s 50-day simple moving average is $1.54 and its two-hundred day simple moving average is $2.13. Harvard Bioscience has a twelve month low of $0.77 and a twelve month high of $4.70. The company has a quick ratio of 0.91, a current ratio of 2.06 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $33.76 million, a price-to-earnings ratio of -2.35 and a beta of 1.46.

Institutional Investors Weigh In On Harvard Bioscience

An institutional investor recently raised its position in Harvard Bioscience stock. Bank of America Corp DE lifted its stake in Harvard Bioscience, Inc. (NASDAQ:HBIO) by 44.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 38,883 shares of the medical instruments supplier’s stock after buying an additional 11,948 shares during the period. Bank of America Corp DE owned approximately 0.09% of Harvard Bioscience worth $82,000 as of its most recent SEC filing. 80.87% of the stock is owned by hedge funds and other institutional investors.

Harvard Bioscience Company Profile

Harvard Bioscience, Inc develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings.